Neuro-Oncology Reviews




Volume 22 Number 2
31 January 2020




Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 2, 31 January






Cohen KJ, et al., PDQ Pediatric Treatment Editorial Board.
Childhood Astrocytomas Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Jan 16. NCBI Bookshelf ID: NBK65944. PMID: 26389382. Review. ˍ




Theeler BJ, Dalal Y, Monje M, Shilatifard A, Suvà ML, Aboud O, Camphausen K, Cordova C, Finch E, Heiss JD, Packer RJ, Romo CG, Aldape K, Penas-Prado M, Armstrong T, Gilbert MR.
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop Proceedings.
Neurooncol Adv. 2020 Jan 16;2(1):vdaa007. doi: 10.1093/noajnl/vdaa007. PMID: 32642676. Review, Meeting Report. ˍ




Feng C, Wu Y, Gao L, Guo X, Wang Z, Xing B.
Publication Landscape Analysis on Gliomas: How Much Has Been Done in the Past 25 Years?
Front Oncol. 2020 Jan 17, 2019;9:1463. doi: 10.3389/fonc.2019.01463. PMID: 32038995. Review. ˍ




Kohno D, Inoue A, Fukushima M, Aki T, Matsumoto S, Suehiro S, Nishikawa M, Ozaki S, Shigekawa S, Watanabe H, Kitazawa R, Kunieda T.
Epithelioid glioblastoma presenting as multicentric glioma: A case report and review of the literature.
Surg Neurol Int. 2020 Jan 17;11:8. doi: 10.25259/SNI_544_2019. PMID: 31966927. Case report, Review. ˍ




Nassiri F, Taslimi S, Wang JZ, Badhiwala JH, Dalcourt T, Ijad N, Pirouzmand N, Almenawer S, Stupp R, Zadeh G.
Determining the optimal adjuvant therapy for improving survival in elderly patients with glioblastoma: a systematic review and meta-analysis.
Clin Cancer Res. 2020 Jan 17;26(11):2664-2672. doi: 10.1158/1078-0432.CCR-19-3359. PMID: 31953312. Systematic review, Meta-analysis. ˍ




Yu W, Zhang L, Wei Q, Shao A.
O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy.
Front Oncol. 2020 Jan 17, 2019;9:1547. doi: 10.3389/fonc.2019.01547. PMID: 32010632. Review. ˍ




Alphandéry E.
Nano-Therapies for Glioblastoma Treatment.
Cancers (Basel). 2020 Jan 19;12(1):E242. doi: 10.3390/cancers12010242. PMID: 31963825. Review. ˍ




Kiskova T, Kubatka P, Büsselberg D, Kassayova M.
The Plant-Derived Compound Resveratrol in Brain Cancer: A Review.
Biomolecules. 2020 Jan 19;10(1):E161. doi: 10.3390/biom10010161. PMID: 31963897. Review. ˍ




Altshuler DB, Kadiyala P, Nuñez FJ, Nuñez FM, Carney S, Alghamri MS, Garcia-Fabiani MB, Asad AS, Nicola Candia AJ, Candolfi M, Lahann J, Moon JJ, Schwendeman A, Lowenstein PR, Castro MG.
Prospects of biological and synthetic pharmacotherapies for glioblastoma.
Expert Opin Biol Ther. 2020 Jan 20;1-13. doi: 10.1080/14712598.2020.1713085. PMID: 31959027. Review. ˍ




Anderson G.
The effects of melatonin on signaling pathways and molecules involved in glioma: Melatonin and glioblastoma: pathophysiology and treatment.
Fundam Clin Pharmacol. 2020 Jan 20;10.1111/fcp.12538. doi: 10.1111/fcp.12538. PMID: 31958165. Editorial. ˍ
Refers to:
Neamati F, et al.,The effects of melatonin on signaling pathways and molecules involved in glioma.
Fundam Clin Pharmacol. 2019 Dec 6, 2020;10.1111/fcp.12526
. doi: 10.1111/fcp.12526. PMID: 31808968. Review. ˍ




Cohen KJ, et al., PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Jan 22. NCBI Bookshelf ID: NBK65812. PMID: 26389253. Review. ˍ




Wang H, Xu T, Huang Q, Jin W, Chen J.
Immunotherapy for Malignant Glioma: Current Status and Future Directions.
Trends Pharmacol Sci. 2020 Jan 20;41(2):123-138. doi: 10.1016/j.tips.2019.12.003. PMID: 31973881. Review. ˍ




Adhikaree J, Moreno-Vicente J, Kaur AP, Jackson AM, Patel PM.
Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma.
Cells. 2020 Jan 21;9(2):E263. doi: 10.3390/cells9020263. PMID: 31973059. Review. ˍ




Cramer SW, Chen CC.
Photodynamic Therapy for the Treatment of Glioblastoma.
Front Surg. 2020 Jan 21, 2019;6:81. doi: 10.3389/fsurg.2019.00081. PMID: 32039232. Review. ˍ




Tunthanathip T, Kanjanapradit K.
Glioblastoma Multiforme Associated with Arteriovenous Malformation: A Case Report and Literature Review.
Ann Indian Acad Neurol. 2020 Jan 21;23(1):103-106. doi: 10.4103/aian.AIAN_219_18? PMID: 32055129. Case report, Review. ˍ




Yekula A, Yekula A, Muralidharan K, Kang K, Carter BS, Balaj L.
Extracellular Vesicles in Glioblastoma Tumor Microenvironment.
Front Immunol. 2020 Jan 21, 2019;10:3137. doi: 10.3389/fimmu.2019.03137. PMID: 32038644. Review. ˍ



.

Chi AS et al, PDQ Adult Treatment Editorial Board.
Adult Central Nervous System Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Jan 22. NCBI Bookshelf ID: NBK65982. PMID: 26389419. Review. ˍ




Gonzalez Castro LN, Milligan TA.
Seizures in patients with cancer.
Cancer. 2020 Jan 22;126(7):1379-1389. doi: 10.1002/cncr.32708. PMID: 31967671. Review. ˍ




Menyhárt O, Győrffy B.
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
Cancer Metastasis Rev. 2020 Jan 22;39(1):211-233. doi: 10.1007/s10555-020-09854-1. PMID: 31970590. Review. ˍ




El Demerdash N, Kedda J, Ram N, Brem H, Tyler B.
Novel therapeutics for brain tumors: current practice and future prospects.
Expert Opin Drug Deliv. 2020 Jan 23;17(1):9-21. doi: 10.1080/17425247.2019.1676227. PMID: 31971041. Review. ˍ




Jeng KS, Chang CF, Lin SS.
Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments.
Int J Mol Sci. 2020 Jan 23;21(3):E758. doi: 10.3390/ijms21030758. PMID: 31979397. Review. ˍ




Moravan MJ, Fecci PE, Anders CK, Clarke JM, Salama AKS, Adamson JD, Floyd SR, Torok JA, Salama JK, Sampson JH, Sperduto PW, Kirkpatrick JP.
Current multidisciplinary management of brain metastases.
Cancer. 2020 Jan 23;126(7):1390-1406. doi: 10.1002/cncr.32714. PMID: 31971613. Review. ˍ




Šamec N, Zottel A, Videtič Paska A, Jovčevska I.
Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma.
Molecules. 2020 Jan 23;25(3):E490. doi: 10.3390/molecules25030490. PMID: 31979318. Review. ˍ




Simonelli M, Dipasquale A, Orzan F, Lorenzi E, Persico P, Navarria P, Pessina F, Nibali MC, Bello L, Santoro A, Boccaccio C.
Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?
Crit Rev Oncol Hematol. 2020 Jan 24;146:102879. doi: 10.1016/j.critrevonc.2020.102879. PMID: 32005411. Review. ˍ




Bozinov O, Yang Y, Oertel MF, Neidert MC, Nakaji P.
Laser interstitial thermal therapy in gliomas.
Cancer Lett. 2020 Jan 25;474:151-157. doi: 10.1016/j.canlet.2020.01.024. PMID: 31991153. Review. ˍ




Rezaei V, Rabiee A, Khademi F.
Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
J Chemother. 2020 Jan 25;1-11. doi: 10.1080/1120009X.2020.1713508. PMID: 31984871. Review. ˍ




Coleman C, Stoller S, Grotzer M, Stucklin AG, Nazarian J, Mueller S.
Pediatric hemispheric high-grade glioma: targeting the future.
Cancer Metastasis Rev. 2020 Jan 27;39(1):245-260. doi: 10.1007/s10555-020-09850-5. PMID: 31989507. Review. ˍ




Takamiya S, Hatanaka KC, Ishi Y, Seki T, Yamaguchi S.
Spinal cord anaplastic astrocytoma with BRAF V600E mutation: A case report and review of literature.
Neuropathology. 2020 Jan 27;40(3):275-279. doi: 10.1111/neup.12636. PMID: 31986557. Review. ˍ




Ciccocioppo F, Lanuti P, Marchisio M, Miscia S.
Extracellular Vesicles Involvement in the Modulation of the Glioblastoma Environment.
J Oncol. 2020 Jan 28;2020:3961735. doi: 10.1155/2020/3961735. PMID: 32411235. Review. ˍ




Dietz MS, Beach CZ, Barajas R, Parappilly MS, Sengupta SK, Baird LC, Ciporen JN, Han SJ, Loret de Mola R, Cho YJ, Nazemi KJ, McClelland S 3rd, Wong MH, Jaboin JJ.
Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade Gliomas.
Adv Radiat Oncol. 2020 Jan 28;5(2):152‐162. doi: 10.1016/j.adro.2019.12.008. PMID: 32280814. Review. ˍ




Drake LR, Hillmer AT, Cai Z.
Approaches to PET Imaging of Glioblastoma.
Molecules. 2020 Jan 28;25(3):568. doi: 10.3390/molecules25030568. PMID: 32012954. Review. ˍ




Zhou Y, Wu W, Bi H, Yang D, Zhang C.
Glioblastoma precision therapy: From the bench to the clinic.
Cancer Lett. 2020 Jan 28;475:79-91. doi: 10.1016/j.canlet.2020.01.027. PMID: 32004571. Review. ˍ




Khan I, Mahfooz S, Hatiboglu MA.
Herbal Medicine for Glioblastoma:Current and Future Prospects.
Med Chem. 2020 Jan 29;16(8):1022-1043. doi: 10.2174/1573406416666200130100833. PMID: 32000653. Review˰ ˍ




Al Ghamdi RM, Turkistani AN, Ben Ali H.
Phenytoin Seizure Prophylaxis Therapy Resulting in Severe Thrombocytopenia After Brain Tumor Debulking Surgery.
Am J Case Rep. 2020 Jan 30;21:e919828. doi: 10.12659/AJCR.919828. PMID: 31996666. Case report, Review. ˍ




Petrelli F, De Stefani A, Ghidini A, Bruschieri L, Riboldi V, Dottorini L, Iaculli A, Zaniboni A, Trevisan F.
Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis.
J Neurol. 2020 Jan 30;268(2):440-447. doi: 10.1007/s00415-020-09731-5. PMID: 32002651. Review. ˍ




Abbruzzese C, Matteoni S, Persico M, Villani V, Paggi MG.
Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps.
J Exp Clin Cancer Res. 2020 Jan 31;39(1):26. doi: 10.1186/s13046-020-1534-z. PMID: 32005270. Editorial. ˍ




Vasilev A, Sofi R, Rahman R, Smith SJ, Teschemacher AG, Kasparov S.
Using Light for Therapy of Glioblastoma Multiforme (GBM).
Brain Sci. 2020 Jan 31;10(2):E75. doi: 10.3390/brainsci10020075. PMID: 32024010. Review. ˍ